ATP5PO
Basic information
Region (hg38): 21:33903453-33915814
Previous symbols: [ "ATP5O" ]
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 7 | AR | Cardiovascular | The condition can include hypertrophic cardiomyopathy, and early diagnosis may enable management | Biochemical; Cardiovascular; Craniofacial; Neurologic | 34954817; 35621276 |
ClinVar
This is a list of variants' phenotypes submitted to
- Mitochondrial complex V (ATP synthase) deficiency, nuclear type 7 (2 variants)
- Severe global developmental delay;Dysphagia;Seizure;Microcephaly (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATP5PO gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 12 | 13 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 2 | 0 | 12 | 1 | 1 |
Variants in ATP5PO
This is a list of pathogenic ClinVar variants found in the ATP5PO region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-33903603-T-C | ATP5PO-related disorder | Likely benign (Jun 06, 2023) | ||
21-33903617-C-G | not specified | Uncertain significance (Sep 29, 2023) | ||
21-33903945-A-G | not specified | Uncertain significance (Nov 19, 2022) | ||
21-33904003-G-C | not specified | Uncertain significance (Jun 05, 2024) | ||
21-33907375-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
21-33907473-T-C | Severe global developmental delay;Dysphagia;Seizure;Microcephaly • Mitochondrial complex V (ATP synthase) deficiency, nuclear type 7 | Pathogenic (Dec 22, 2021) | ||
21-33909089-A-G | Benign (Feb 11, 2022) | |||
21-33909096-G-A | not specified | Uncertain significance (May 08, 2023) | ||
21-33909156-C-A | not specified | Uncertain significance (Dec 22, 2023) | ||
21-33909168-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
21-33914447-T-C | ATP5PO-related disorder • Leigh syndrome • Mitochondrial complex V (ATP synthase) deficiency, nuclear type 7 | Pathogenic/Likely pathogenic (Aug 09, 2020) | ||
21-33914463-G-C | not specified | Uncertain significance (Mar 22, 2023) | ||
21-33914467-A-G | not specified | Uncertain significance (Mar 28, 2023) | ||
21-33914499-A-G | not specified | Uncertain significance (Nov 08, 2022) | ||
21-33915730-G-A | Severe global developmental delay;Dysphagia;Seizure;Microcephaly • Mitochondrial complex V (ATP synthase) deficiency, nuclear type 7 | Pathogenic (Dec 22, 2021) | ||
21-33915744-G-C | not specified | Uncertain significance (Feb 05, 2024) | ||
21-33915745-A-G | not specified | Uncertain significance (Nov 09, 2021) | ||
21-33915757-C-A | not specified | Uncertain significance (Oct 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATP5PO | protein_coding | protein_coding | ENST00000290299 | 7 | 12528 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0581 | 0.926 | 125738 | 0 | 9 | 125747 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0269 | 117 | 118 | 0.993 | 0.00000640 | 1347 |
Missense in Polyphen | 18 | 25.107 | 0.71693 | 364 | ||
Synonymous | -0.479 | 48 | 44.0 | 1.09 | 0.00000233 | 433 |
Loss of Function | 2.10 | 4 | 11.8 | 0.339 | 6.47e-7 | 139 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000149 | 0.000149 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/ATP6 static relative to the rotary elements.;
- Pathway
- Alzheimer,s disease - Homo sapiens (human);Huntington,s disease - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Parkinson,s disease - Homo sapiens (human);Electron Transport Chain;Oxidative phosphorylation;Formation of ATP by chemiosmotic coupling;The citric acid (TCA) cycle and respiratory electron transport;Purine metabolism;Metabolism;Cristae formation;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Organelle biogenesis and maintenance
(Consensus)
Recessive Scores
- pRec
- 0.300
Intolerance Scores
- loftool
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.01
Haploinsufficiency Scores
- pHI
- 0.0813
- hipred
- Y
- hipred_score
- 0.519
- ghis
- 0.549
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Atp5o
- Phenotype
Zebrafish Information Network
- Gene name
- atp5po
- Affected structure
- anatomical system
- Phenotype tag
- abnormal
- Phenotype quality
- quality
Gene ontology
- Biological process
- ATP biosynthetic process;cristae formation;mitochondrial ATP synthesis coupled proton transport;ATP hydrolysis coupled cation transmembrane transport;proton transmembrane transport
- Cellular component
- nucleus;mitochondrion;mitochondrial inner membrane;mitochondrial proton-transporting ATP synthase complex;plasma membrane
- Molecular function
- transporter activity;protein binding;drug binding;ATPase activity;transmembrane transporter activity;proton-transporting ATP synthase activity, rotational mechanism